Observational studyInternational journal of molecular sciences2025

Real-World Safety and Effectiveness of Elexacaftor, Tezacaftor, and Ivacaftor in People with Cystic Fibrosis and Advanced Lung Disease: A Two-Year Multicenter Cohort Study.

Sonia Volpi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.